Hoth Therapeutics, Inc. HOTH
0.80 USD 0.00 (+0.00%)
Aug 5, 2026, 3:59 PM EDT
0.7911 Day range 0.835
52-week range unavailable
- YTD
- -19.06%
- 1 year
- -43.57%
Analyst view
Price target (mean) 4.50 +461.6% upside
Now 0.8013
- Target (low)
- 4.00
- Target (mean)
- 4.50
- Target (high)
- 5.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 3
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.26 | -0.26 – -0.26 | -0.31 | +16.1% | 0 | 0.0% | 1 |
| Next quarter | -0.25 | -0.25 – -0.25 | -0.46 | +45.7% | 0 | 0.0% | 1 |
| Current year | -1.54 | -1.90 – -1.18 | -2.30 | +33.0% | 0 | 0.0% | 2 |
| Next year | -0.87 | -0.87 – -0.87 | -1.54 | +43.5% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 5, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 2, 2024 | EF Hutton | Maintained | Buy | Buy |
| Feb 5, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Sep 14, 2023 | EF Hutton | Maintained | Buy | Buy |
| Jun 20, 2023 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Apr 27, 2023 | EF Hutton | Reiterated | — | Buy |
| Apr 10, 2023 | Benchmark | Reiterated | — | Speculative Buy |
| Apr 3, 2023 | EF Hutton | Maintained | — | Buy |
| Dec 30, 2022 | EF Hutton | Maintained | — | Buy |